These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 17606036)
1. Value of high-resolution computed tomography and magnetic resonance imaging in the detection of residual cholesteatomas in primary bony obliterated mastoids. De Foer B; Vercruysse JP; Pouillon M; Somers T; Casselman JW; Offeciers E Am J Otolaryngol; 2007; 28(4):230-4. PubMed ID: 17606036 [TBL] [Abstract][Full Text] [Related]
2. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings. Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491 [TBL] [Abstract][Full Text] [Related]
3. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance. Bernardeschi D; Law-Ye B; Bielle F; Hochet B; Sterkers O; Dormont D; Pyatigorskaya N Eur Radiol; 2019 Oct; 29(10):5617-5626. PubMed ID: 30888487 [TBL] [Abstract][Full Text] [Related]
4. Detection of postoperative residual cholesteatoma with non-echo-planar diffusion-weighted magnetic resonance imaging. De Foer B; Vercruysse JP; Bernaerts A; Deckers F; Pouillon M; Somers T; Casselman J; Offeciers E Otol Neurotol; 2008 Jun; 29(4):513-7. PubMed ID: 18520587 [TBL] [Abstract][Full Text] [Related]
5. Correlation of computed tomography, echo-planar diffusion-weighted magnetic resonance imaging and surgical outcomes in middle ear cholesteatoma. Songu M; Altay C; Onal K; Arslanoglu S; Balci MK; Ucar M; Ciger E; Kopar A Acta Otolaryngol; 2015 Aug; 135(8):776-80. PubMed ID: 25812909 [TBL] [Abstract][Full Text] [Related]
6. Postoperative non-echo-planar diffusion-weighted magnetic resonance imaging changes after cholesteatoma surgery: implications for cholesteatoma screening. Dhepnorrarat RC; Wood B; Rajan GP Otol Neurotol; 2009 Jan; 30(1):54-8. PubMed ID: 19092558 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of delayed postcontrast magnetic resonance imaging in the detection of residual cholesteatoma after canal wall-up tympanoplasty. Ayache D; Williams MT; Lejeune D; Corré A Laryngoscope; 2005 Apr; 115(4):607-10. PubMed ID: 15805868 [TBL] [Abstract][Full Text] [Related]
8. Does Diffusion-Weighted MR Imaging Change the Follow-Up Strategy in Cases with Residual Cholesteatoma? Dündar Y; Akcan FA; Dilli A; Tatar E; Korkmaz H; Özdek A J Int Adv Otol; 2015 Apr; 11(1):58-62. PubMed ID: 26223720 [TBL] [Abstract][Full Text] [Related]
9. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma. Migirov L; Wolf M; Greenberg G; Eyal A Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217 [TBL] [Abstract][Full Text] [Related]
10. Imaging for evaluation of cholesteatoma: current concepts and future directions. Corrales CE; Blevins NH Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):461-7. PubMed ID: 23880648 [TBL] [Abstract][Full Text] [Related]
12. Value of Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging for Detecting Tympanomastoid Cholesteatoma. Yiğiter AC; Pınar E; İmre A; Erdoğan N J Int Adv Otol; 2015 Apr; 11(1):53-7. PubMed ID: 26223719 [TBL] [Abstract][Full Text] [Related]
13. [The role of high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI) in the diagnosis of preoperative and postoperative complications caused by acquired cholesteatomas]. Krestan C; Czerny C; Gstöttner W; Franz P Radiologe; 2003 Mar; 43(3):207-12. PubMed ID: 12664235 [TBL] [Abstract][Full Text] [Related]
14. Use of mastoid obliteration techniques in cholesteatoma. Yung M; Bennett A Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728 [TBL] [Abstract][Full Text] [Related]
15. Imaging of postoperative middle ear cholesteatoma. Khemani S; Singh A; Lingam RK; Kalan A Clin Radiol; 2011 Aug; 66(8):760-7. PubMed ID: 21524417 [TBL] [Abstract][Full Text] [Related]
16. Negative Predictive Value of Non-Echo-Planar Diffusion Weighted MR Imaging for the Detection of Residual Cholesteatoma Done at 9 Months After Primary Surgery Is not High Enough to Omit Second Look Surgery. Horn RJ; Gratama JWC; van der Zaag-Loonen HJ; Droogh-de Greve KE; van Benthem PG Otol Neurotol; 2019 Aug; 40(7):911-919. PubMed ID: 31219966 [TBL] [Abstract][Full Text] [Related]
17. MRI, not CT, to rule out recurrent cholesteatoma and avoid unnecessary second-look mastoidectomy. Migirov L; Tal S; Eyal A; Kronenberg J Isr Med Assoc J; 2009 Mar; 11(3):144-6. PubMed ID: 19544702 [TBL] [Abstract][Full Text] [Related]
18. Detection of postoperative relapsing/residual cholesteatomas with diffusion-weighted echo-planar magnetic resonance imaging. Stasolla A; Magliulo G; Parrotto D; Luppi G; Marini M Otol Neurotol; 2004 Nov; 25(6):879-84. PubMed ID: 15547415 [TBL] [Abstract][Full Text] [Related]
19. The value of non-echo planar HASTE diffusion-weighted MR imaging in the detection, localisation and prediction of extent of postoperative cholesteatoma. Khemani S; Lingam RK; Kalan A; Singh A Clin Otolaryngol; 2011 Aug; 36(4):306-12. PubMed ID: 21564557 [TBL] [Abstract][Full Text] [Related]
20. HASTE diffusion-weighted MRI for the reliable detection of cholesteatoma. Ilıca AT; Hıdır Y; Bulakbaşı N; Satar B; Güvenç I; Arslan HH; Imre N Diagn Interv Radiol; 2012; 18(2):153-8. PubMed ID: 21960134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]